Ann: Paradigm to present at Virtual Conference, Friday 27th March, page-26

Mozz's notes form conference

PART 4

1) (Mozz's notes: this is very exciting) Paul said that the "TGA agreed that there is an unmet clinical need for Zilosul to treat OA". if I had access to a printer (Mine is a bit crappy) I'd print this out in bold and stick it on my PAR wall next to my degree!!!)


(Mozz's notes: This is the golden line..maybe the most important so far...yes yes we know this as shareholders and avid followers but for them [TGA] to say that has real bearing...


2) In terms of Chronic pain investigation and our effect of iPPS on this PAR will set up a small trial to begin this work in this area. It may initially involve animal studies and then progress to humans. (Mozz's notes: Again part of the excitement as we explore this new area).



3) There were some super questions I could see come up...but Paul ran completely out of time...how does one sum up what we have in 30 mins along with questions? Impossible. Not sure if these will get answered, it might get answered via email to the people that asked them?

Some examples of questions:

Q1 "For IPPS do you see a difference in effectiveness between age groups?"

Q2 "Does the exclusive agreement with Bene cover US and Europe?"


I think that's all the notes I had but If I dig up any more there will be a part 5 later today...


Glad I attended!

DYOR